Literature DB >> 1846422

Effects of nitroglycerin on ATP-induced Ca(++)-mobilization, Ca(++)-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery.

K Fujino1, S Nakaya, T Wakatsuki, Y Miyoshi, Y Nakaya, H Mori, I Inoue.   

Abstract

Extracellular application of ATP transiently increases the cytosolic-free Ca++ concentration ([Ca++]i) in cultured smooth muscle cells of porcine coronary artery, and this activates large conductance Ca(++)-activated K (Kca) channels. In the present study effects of nitroglycerin (NG) and 4-aminopyridine (4-AP) on [Ca++]; and contraction were studied. 4-AP blocked Kca channels and enhanced the rise of [Ca++]i with oscillation, which led to contraction of the cells. NG activated the Kca channels of 300 picosiemens and inhibited 4-AP-induced contraction and oscillation of [Ca++]i. These results suggest that the vasorelaxant effect of NG involves hyperpolarization of the cell membrane by activating the Kca channels. NG also cause rapid decrease of [Ca++]i during the Ca(++)-mobilization by ATP in Ca-free solution. Similar effects were observed with cyclic GMP, suggesting that the effects of NG on the Kca channels and [Ca++]i were mediated by cyclic GMP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846422

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Abnormal activation of K(+) channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence.

Authors:  S J Chen; C C Wu; S N Yang; C I Lin; M H Yen
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

Authors:  S L Archer; J M Huang; V Hampl; D P Nelson; P J Shultz; E K Weir
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

Review 5.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

6.  Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.

Authors:  M D Randall; H Ujiie; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Evidence for the Involvement of Potassium Channel Inhibition in the Antidepressant-Like Effects of Hesperidin in the Tail Suspension Test in Mice.

Authors:  Franciele Donato; Carlos Borges Filho; Renata Giacomeli; Elza Eliza Tenório Alvater; Lucian Del Fabbro; Michele da Silva Antunes; Marcelo Gomes de Gomes; André Tiago Rossito Goes; Leandro Cattelan Souza; Silvana Peterini Boeira; Cristiano Ricardo Jesse
Journal:  J Med Food       Date:  2015-02-03       Impact factor: 2.786

8.  Nitroglycerin inhibits the phosphorylation of intermediate filament proteins rather than myosin light chain on porcine coronary artery sustained contraction.

Authors:  S Ishibashi; K Kawasaki; Y Tate; T Ihara; K Shimada
Journal:  Experientia       Date:  1995-09-29

9.  S-nitrosocysteine, but not sodium nitroprusside, produces apamin-sensitive hyperpolarization in rat gastric fundus.

Authors:  K Kitamura; Q Lian; A Carl; H Kuriyama
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.

Authors:  M D Randall; T M Griffith
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.